Figure 5 | Scientific Reports

Figure 5

From: MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model

Figure 5

TLR2, TLR4, TLR7, and TLR9 receptors do not interfere in tumor regression in response to BCG treatment. C57BL/6 WT, TLR2−/−, TLR4−/−, TLR7−/− and TLR9−/− mice were submitted to the subcutaneous tumor model and BCG treatment. Tumor growth curves are shown for TLR2−/− (A), TLR4−/− (B), TLR7−/− (C) and TLR9−/− (D). The final volumes (day 22) are shown in Figure (E). Data represents mean and standard deviation from the results of at least two independent experiments. C57BL/6 WT data represents the summary of control animals from all in vivo experiments comparing WT and KO mice. *Statistically significant compared to the respective untreated control, ****P ≤ 0.0001. #Statistically significant compared to C57BL/6 WT mock not treated, #P ≤ 0.05, ##P ≤ 0.01, ####P ≤ 0.0001.

Back to article page